Young adults, blacks, cisgender women, and people in rural areas, as well as people on Medicaid, were less likely to persist on PrEP.
The Fair Pricing Coalition is working with pharmaceutical companies to ensure fair prices for new HIV drugs on par with those of older medications.
The lack of Medicaid expansion in the South is creating worse racial disparities in the U.S., according to researchers and medical providers discussing the HIV care cascade at CROI 2018.
Due to the impact of the Affordable Care Act (ACA), in just two years the proportion of people living with HIV in care covered by Medicaid increased from 36% to 42% and the proportion that were uninsured fell from 18% to 14%.
"Drug prices are too high and your access to your drugs is in danger. So, wake up and get ready!" says Lynda Dee of the Fair Pricing Coalition.
The introduction of three new antiretrovirals into treatment programmes in low- and middle-income countries -- tenofovir alafenamide fumarate (TAF), low-dose efavirenz (Sustiva, Stocrin) and dolutegravir (Tivicay, DTG) -- could represent over $3 bill...
Lynda Dee of the Fair Pricing Coalition (FPC) spoke with coworkers Jeff Berry and Murray Penner, as well as David Evans of Project Inform, about access to HIV and hepatitis C (HCV) medications. FPC negotiates with pharmaceutical companies to make the...